Table 1.
Samples | Age at operation in years | Sex | RF | Diagnosis | Medication | Synovial pannus cells |
---|---|---|---|---|---|---|
JCA | ||||||
G 12 | 13 | m | 0 | JCA (systemic) | CyA, Pred,SSZ, NSAID | fr |
G 16 | 3 | m | 0 | JCA (systemic) | Pred, SSZ, NSAID | fr |
G/Z 26 | 12 | m | 0 | JCA (systemic) | Pred, SSZ | fr/c |
G 1 | 2 | f | 0 | JCA (poly) | MTX, NSAID | fr |
G 10 | 9 | f | 0 | JCA (poly) | Pred, Gold | fr |
G 11 | 12 | m | 0 | JCA (poly) | MTX, Pred, SSZ | fr |
G 20 | 13 | f | 0 | JCA (poly) | Pred, NSAID | fr |
G 22 | 7 | m | + | JCA (poly) | Pred, SSZ | fr |
G 2 | 14 | m | 0 | JCA (pauci), iridocyclitis | Pred, SSZ | fr |
G 7 | 20 | m | + | JCA(pauci) | Pred, SSZ, NSAID | fr |
G 14 | 15 | f | (+) | JCA (pauci) | SSZ, NSAID | fr |
G 23 | 11 | f | + | JCA (pauci) | Pred, SSZ, NSAID | fr |
G 25 | 7 | m | 0 | JCA (pauci) | SSZ | fr |
G 44 | 14 | m | + | JCA/psoriasis | Pred, SSZ | fr |
G 48 | 10 | f | 0 | JCA/tendovaginitis | NSAID | c |
G 24 | 6 | m | 0 | JCA/sarcoidosis | Leukeran, NSAID, Pred | fr |
RA | ||||||
G/Z 4 | 61 | f | 0 | RA + SLE | Pred, Azathioprin | fr/c |
G/Z 5 | 70 | f | + | RA | Pred, Tauredon, NSAID | fr/c |
G 9 | 71 | f | + | RA | MTX, Pred, NSAID | fr |
G 13 | 40 | f | + | RA | Azathioprin | fr |
G 15 | 41 | f | + | RA | SSZ | fr |
G 17 | 61 | f | + | RA | Azathioprin, NSAID | fr |
G 21 | 27 | f | 0 | RA | SSZ, Tauredon, NSAID | fr |
G 28 | 58 | f | 0 | RA | Chloroquine | fr |
G 31 | 34 | f | (+) | RA | MTX, Pred, NSAID | fr |
G 32 | 62 | f | + | RA | Pred | fr |
G 36 | 64 | f | 0 | RA | MTX, Pred | fr |
G 37 | 63 | f | + | RA | MTX, Pred | fr |
G 46 | 76 | f | + | RA | Predni, Azathioprin | fr |
G 47 | 65 | f | (+) | RA | Predni, Endoxan | fr |
G 49 | 53 | m | 0 | RA | MTX, Pred, NSAID | fr |
Poly, polyarticular onset; pauci, pauciarticular course; systemic, systemic course; SLE, systemic lupus erythematosus; RF, rheumatic factor; Pred, prednison; MTX, methotrexate; NSAID, nonsteroidal anti-inflammatory drugs; SSZ, sulphasalazine; fr, frozen tissue; c, culture of synovial fibroblast cells; +, positive; (+), weak positive; 0, negative.